Michael Danquah, Ph.D.
Affiliations: | 2012 | Pharmaceutical Sciences | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Pharmacy, Nanotechnology, OncologyGoogle:
"Michael Danquah"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ram I. Mahato | grad student | 2012 | UTHSC | |
| (Nanotherapies for treating prostate cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Danquah M. (2022) Embelin and Its Derivatives: Design, Synthesis, and Potential Delivery Systems for Cancer Therapy. Pharmaceuticals (Basel, Switzerland). 15 |
| Ibrahim Q, Patel R, Boamah E, et al. (2017) Gene Expression Profiling of Triple Negative Breast Cancer Cells Treated with Afatinib Journal of Pharmaceutical Research International. 19: 1-13 |
| Tan KX, Danquah MK, Sidhu A, et al. (2016) Towards targeted cancer therapy: Aptamer or oncolytic virus? European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences |
| Shah P, Djisam R, Damulira H, et al. (2016) Embelin inhibits proliferation, induces apoptosis and alters gene expression profiles in breast cancer cells. Pharmacological Reports : Pr. 68: 638-44 |
| Danquah M. (2016) Abstract 2060: Polymer mediated RNAi-based combination therapy for treating prostate cancer Cancer Research. 76: 2060-2060 |
| Wen D, Danquah M, Chaudhary AK, et al. (2015) Small molecules targeting microRNA for cancer therapy: Promises and obstacles. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Boamah E, Ibrahim Q, Kwinji L, et al. (2015) EGFR inhibitors in combination with cyclopamine as chemotherapeutic strategy for treating breast cancer Synergy. 2: 7-18 |
| Wen D, Chitkara D, Wu H, et al. (2014) LHRH-conjugated micelles for targeted delivery of antiandrogen to treat advanced prostate cancer. Pharmaceutical Research. 31: 2784-95 |
| Danquah M. (2014) Polycarbonate Micelles for Cancer Therapy Journal of Cancer Science & Therapy. 6 |
| Mundra V, Lu Y, Danquah M, et al. (2012) Formulation and characterization of polyester/polycarbonate nanoparticles for delivery of a novel microtubule destabilizing agent. Pharmaceutical Research. 29: 3064-74 |